Literature DB >> 20546124

Adipokines are associated with lower extremity venous disease: the San Diego population study.

M A Allison1, M Cushman, P W Callas, J O Denenberg, N E Jensky, M H Criqui.   

Abstract

BACKGROUND: Obesity is a risk factor for venous disease. We tested the associations between adipokines and the presence and severity of venous disease.
METHODS: Participants for this analysis were drawn from a cohort of 2408 employees and retirees of a university in San Diego who were examined for venous disease using duplex ultrasonography. From this cohort, a case-control study sample of all 352 subjects with venous disease and 352 age-, sex- and race-matched subjects without venous disease were included in this analysis. All subjects completed health history questionnaires, had a physical examination with anthropometric measurements and had venous blood analyzed for adipokines.
RESULTS: After adjustment for age, sex and race, those with venous disease had significantly higher levels of body mass index (BMI), leptin and interleukin-6. Levels of resistin and tumor necrosis factor-alpha were also higher but of borderline significance (0.05 < P < 0.10). Compared with the lowest tertile and with adjustment for age, sex, race and BMI, the 2nd and 3rd tertiles of resistin (odds ratios, 1.9 and 1.7, respectively), leptin (1.7 and 1.7) and tumor necrosis factor-alpha (1.4 and 1.7) were associated with increasing severity of venous disease. Conversely, a 5 kg m⁻² increment in BMI was associated with a higher odds ratio (1.5) for venous disease, which was independent of the adipokines included in this study.
CONCLUSIONS: Both obesity and adipokines are significantly associated with venous disease. These associations appear to be independent of each other, suggesting potentially different pathways to venous disease.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546124      PMCID: PMC4078899          DOI: 10.1111/j.1538-7836.2010.03941.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  33 in total

Review 1.  Central actions of adipocyte hormones.

Authors:  Rexford S Ahima
Journal:  Trends Endocrinol Metab       Date:  2005-09       Impact factor: 12.015

Review 2.  The metabolic syndrome and the risk of arterial and venous thrombosis.

Authors:  Massimo Franchini; Giovanni Targher; Martina Montagnana; Giuseppe Lippi
Journal:  Thromb Res       Date:  2007-11-08       Impact factor: 3.944

3.  Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.

Authors:  Ching-Chu Chen; Tsai-Chung Li; Chia-Ing Li; Chiu-Shong Liu; Hui-Ju Wang; Cheng-Chieh Lin
Journal:  Metabolism       Date:  2005-04       Impact factor: 8.694

Review 4.  Adipose tissue, adipokines, and inflammation.

Authors:  Giamila Fantuzzi
Journal:  J Allergy Clin Immunol       Date:  2005-05       Impact factor: 10.793

5.  Adiponectin expression and adipose tissue lipolytic activity in lean and obese women.

Authors:  Mónica Bulló; Jordi Salas-Salvadó; Pilar García-Lorda
Journal:  Obes Surg       Date:  2005-03       Impact factor: 4.129

6.  Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity.

Authors:  Lalita Khaodhiar; Pei-Ra Ling; George L Blackburn; Bruce R Bistrian
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Nov-Dec       Impact factor: 4.016

Review 7.  The entero-insular axis and adipose tissue-related factors in the prediction of weight gain in humans.

Authors:  M-F Hivert; M-F Langlois; A C Carpentier
Journal:  Int J Obes (Lond)       Date:  2006-11-28       Impact factor: 5.095

8.  Relationships between symptoms and venous disease: the San Diego population study.

Authors:  Robert D Langer; Elena Ho; Julie O Denenberg; Arnost Fronek; Matthew Allison; Michael H Criqui
Journal:  Arch Intern Med       Date:  2005-06-27

9.  Adipokines, insulin resistance, and coronary artery calcification.

Authors:  Atif Qasim; Nehal N Mehta; Mahlet G Tadesse; Megan L Wolfe; Thomas Rhodes; Cynthia Girman; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

10.  Leptin, the product of Ob gene, promotes angiogenesis.

Authors:  A Bouloumié; H C Drexler; M Lafontan; R Busse
Journal:  Circ Res       Date:  1998-11-16       Impact factor: 17.367

View more
  7 in total

1.  Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry).

Authors:  Reza Mirza; Robby Nieuwlaat; Juan J López-Núñez; Raquel Barba; Arnav Agarwal; Carme Font; Maurizio Ciammaichella; Elvira Grandone; Rick Ikesaka; Mark Crowther; Manuel Monreal
Journal:  Blood Adv       Date:  2020-06-09

2.  Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology.

Authors:  Mary Cushman; Ellen S O'Meara; Susan R Heckbert; Neil A Zakai; Wayne Rosamond; Aaron R Folsom
Journal:  Thromb Res       Date:  2016-06-15       Impact factor: 3.944

3.  Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population Study.

Authors:  Locke J Bryan; Peter W Callas; Michael H Criqui; Mary Cushman
Journal:  Thromb Res       Date:  2012-08-12       Impact factor: 3.944

Review 4.  Cutaneous sequelae of a national health crisis: Obesity and the skin.

Authors:  C Cotter; S Walsh
Journal:  Skin Health Dis       Date:  2020-11-04

5.  Obesity measures and risk of venous thromboembolism and myocardial infarction.

Authors:  Lars D Horvei; Sigrid K Brækkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Eur J Epidemiol       Date:  2014-09-12       Impact factor: 8.082

6.  Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease.

Authors:  Pedro Serralheiro; António Novais; Elisa Cairrão; Cláudio Maia; Carlos M Costa Almeida; Ignacio Verde
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

7.  Elevated leptin and decreased adiponectin independently predict the post-thrombotic syndrome in obese and non-obese patients.

Authors:  Sandra Mrozinska; Joanna Cieslik; Elżbieta Broniatowska; Anetta Undas
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.